Regional Monitoring EECA
by ECUO PLWH
Showing 1-6 of 6 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps6.496-30194.88--National Health Service (NHC)2016Not specifiedNot specifiedNot specified
2Russian FederationGovernmentAurobindo Pharma Ltd.DidanosineDidanosine400mg caps1.39217098503041.76569952380111.252015Not specifiedNot specifiedNot specified
3Republic of ArmeniaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.733318903022631386VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
4Republic of LatviaGovernmentBristol-Myers SquibbVidexDidanosine400mg caps5.61473030168.441168.442015Not specifiedNot specifiedNot specified
5Russian FederationGovernmentBristol-Myers SquibbVidexDidanosine400mg caps1.40113008303042.03433611822462.882015Not specifiedNot specifiedNot specified
6GeorgiaGlobal FundAurobindo Pharma Ltd.Didanosine400mg caps0.666718003020601200partnership for supply. chain management (PFSCM)2015NoNot specifiedNot specified